New Jersey-based Johnson & Johnson plans coronavirus vaccine trial involving 60,000 people
New Brunswick-based Johnson & Johnson plans to roll out a vaccine trial involving 60,000 people, possibly making it the largest late-stage trial.
•
Aug 21, 2020, 10:09 AM
•
Updated 1,564 days ago
Share:
More Stories
0:33
US Supreme Court rejects appeal on Rutgers University COVID-19 vaccine mandate case
161ds ago
Nobel in medicine goes to 2 scientists whose work enabled creation of mRNA vaccines against COVID-19
427ds ago0:21
Biden administration announces $600M to produce COVID tests and will reopen website to order them
439ds ago
Murphy administration: No plans to implement any COVID-19 restrictions
445ds ago0:39
Cape May hospital asking patients to wear mask amid COVID surge
446ds ago2:57
Lawmakers call for investigation, overhaul following DOJ report about NJ’s COVID response in veterans homes
448ds ago0:33
US Supreme Court rejects appeal on Rutgers University COVID-19 vaccine mandate case
161ds agoNobel in medicine goes to 2 scientists whose work enabled creation of mRNA vaccines against COVID-19
427ds ago0:21
Biden administration announces $600M to produce COVID tests and will reopen website to order them
439ds agoMurphy administration: No plans to implement any COVID-19 restrictions
445ds ago0:39
Cape May hospital asking patients to wear mask amid COVID surge
446ds ago2:57
Lawmakers call for investigation, overhaul following DOJ report about NJ’s COVID response in veterans homes
448ds agoNew Brunswick-based Johnson & Johnson plans to roll out a vaccine trial involving 60,000 people, possibly making it the largest late-stage trial.
PHOTOS: COVID-19 Impacts the World
Testing begins next month.
VIRUS TRACKER: New York, New Jersey, Connecticut coronavirus cases and deaths
MORE: LIVE BLOG - Coronavirus updates from the tri-state area and beyond
MORE: New Jersey Coronavirus Dashboard
FULL COVERAGE: Coronavirus Pandemic
MORE: LIVE BLOG - Coronavirus updates from the tri-state area and beyond
MORE: New Jersey Coronavirus Dashboard
FULL COVERAGE: Coronavirus Pandemic
According to details of the trial, participants, healthy people ages 18 and older across nearly 180 locations, will be randomly selected to receive the potential vaccine or placebo. This will help determine whether the vaccine is safe and effective.
MORE: 10 ways to stay safe when dining at restaurants
MORE: 15 questions to ask yourself before venturing out during COVID-19
MORE: 10 ways to stay safe when returning to the gym/fitness center
MORE: 7 things to remember when going to a nail salon
MORE: 15 questions to ask yourself before venturing out during COVID-19
MORE: 10 ways to stay safe when returning to the gym/fitness center
MORE: 7 things to remember when going to a nail salon
The phase three trial would be the largest test of a coronavirus vaccine yet.
More from News 12
2:00
Overhead wire damage causes train disruptions at Newark Penn Station
1:43
Police address increase in NJ roadway deaths over holiday weekend
1:54
Bitter beginning to December in New Jersey continues. Could snow make for cumbersome commute Thursday morning?
1:57
Somerset County prosecutors: Man charged with murder in 1997 death of Tamara Tignor
0:36
NJ woman sentenced to 25 years in prison for driving drunk and killing bride in South Carolina
2:02
